Financial Times: Pharma giants see future of lower health care profits
“For the hundreds of executives gathered in London recently for the FT’s annual pharmaceutical conference, the words of GlaxoSmithKline chief Sir Andrew Witty highlighted the problems facing the industry in the decades ahead. Despite pouring many billions of dollars into new treatments and extending lives in ways that were merely a dream a few years ago, drugmakers may have to get used to making less money. … The social contract between citizens and pharmaceutical companies — rocked by a string of recent pricing scandals — is fraying…” The article is part of a special report titled “Innovation in Healthcare” (Viña, 11/29).